Hydroxychloroquine as an anti-thrombotic in antiphospholipid syndrome
- 1 April 2015
- journal article
- review article
- Published by Elsevier in Autoimmunity Reviews
- Vol. 14 (4) , 358-362
Abstract
No abstract availableKeywords
This publication has 58 references indexed in Scilit:
- Correct laboratory approach to APS diagnosis and monitoringAutoimmunity Reviews, 2013
- Thrombotic recurrences and bleeding events in APS vascular patients: A review from the literature and a comparison with the APS Piedmont CohortAutoimmunity Reviews, 2012
- Revised Recommendations on Screening for Chloroquine and Hydroxychloroquine RetinopathyOphthalmology, 2011
- Hydroxychloroquine protects the annexin A5 anticoagulant shield from disruption by antiphospholipid antibodies: evidence for a novel effect for an old antimalarial drugBlood, 2010
- Clinical efficacy and side effects of antimalarials in systemic lupus erythematosus: a systematic reviewAnnals of the Rheumatic Diseases, 2010
- Risk and protective factors for thrombosis in systemic lupus erythematosus: results from a large, multi-ethnic cohortAnnals of the Rheumatic Diseases, 2009
- Hydroxychloroquine directly reduces the binding of antiphospholipid antibody–β2-glycoprotein I complexes to phospholipid bilayersBlood, 2008
- Antiphospholipid antibodies induce vascular functional changes in mice: a mechanism of vascular lesions in antiphospholipid syndrome?Lupus, 2008
- Effect of hydroxychloroquine on the survival of patients with systemic lupus erythematosus: data from LUMINA, a multiethnic US cohort (LUMINA L)Annals of the Rheumatic Diseases, 2007
- Hydroxychloroquine Effects on Lipoprotein Profiles (the HELP trial)JCR: Journal of Clinical Rheumatology, 1997